Onyx Bridge Wealth Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
6,409
+255
+4% +$54.9K 0.15% 121
2026
Q1
$1.34M Buy
6,154
+64
+1% +$14.2K 0.14% 125
2025
Q4
$1.39M Buy
6,090
+136
+2% +$31K 0.15% 121
2025
Q3
$1.38M Buy
5,954
+600
+11% +$122K 0.15% 115
2025
Q2
$994K Sell
5,354
-317
-6% -$58.9K 0.13% 122
2025
Q1
$1.19M Buy
5,671
+148
+3% +$28.8K 0.17% 95
2024
Q4
$981K Buy
5,523
+399
+8% +$73.4K 0.14% 102
2024
Q3
$1.01M Buy
5,124
+23
+0.5% +$4.29K 0.15% 103
2024
Q2
$875K Sell
5,101
-19
-0.4% -$3.15K 0.14% 104
2024
Q1
$817K Buy
5,120
+136
+3% +$23.4K 0.15% 106
2023
Q4
$772K Buy
4,984
+14
+0.3% +$2.04K 0.16% 100
2023
Q3
$741K Sell
4,970
-703
-12% -$103K 0.17% 90
2023
Q2
$764K Buy
5,673
+2,115
+59% +$310K 0.18% 97
2023
Q1
$567K Buy
3,558
+104
+3% +$15.9K 0.23% 79
2022
Q4
$575K Sell
3,454
-88
-2% -$13.5K 0.23% 70
2022
Q3
$496K Buy
3,542
+1,927
+119% +$277K 0.23% 76
2022
Q2
$240K Sell
1,615
-482
-23% -$73.7K 0.11% 123
2022
Q1
$331K Sell
2,097
-244
-10% -$35.4K 0.13% 95
2021
Q4
$317K Buy
2,341
+47
+2% +$5.55K 0.11% 110
2021
Q3
$246K Sell
2,294
-104
-4% -$11.9K 0.09% 122
2021
Q2
$282K Buy
+2,398
New +$270K 0.12% 85

Other funds holding ABBV

Onyx Bridge Wealth Group's ABBV Position: Q2 2026 in Review

Onyx Bridge Wealth Group increased its AbbVie (ABBV) stake by 4.1% in Q2 2026, buying an estimated $54.9K and bringing the position to 6,409 shares worth $1.61M. The position accounts for 0.15% of the portfolio, ranked #121.

Onyx Bridge Wealth Group first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 1,651 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Onyx Bridge Wealth Group held 6,409 shares of AbbVie worth $1.61M as of Q2 2026.
  • Onyx Bridge Wealth Group bought 255 AbbVie shares in Q2 2026, an estimated $54.9K.
  • AbbVie made up 0.15% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #121 holding.
  • Onyx Bridge Wealth Group first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • 1,651 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.